[HTML][HTML] Ten years of lateral flow immunoassay technique applications: Trends, challenges and future perspectives

F Di Nardo, M Chiarello, S Cavalera, C Baggiani… - Sensors, 2021 - mdpi.com
The Lateral Flow Immunoassay (LFIA) is by far one of the most successful analytical
platforms to perform the on-site detection of target substances. LFIA can be considered as a …

Approaches to objectively measure antiretroviral medication adherence and drive adherence interventions

MA Spinelli, JE Haberer, PR Chai… - Current Hiv/Aids …, 2020 - Springer
Abstract Purpose of Review Traditional methods to assess antiretroviral adherence, such as
self-report, pill counts, and pharmacy refill data, may be inaccurate in determining actual pill …

The future of HIV pre-exposure prophylaxis adherence: reducing barriers and increasing opportunities

JE Haberer, A Mujugira, KH Mayer - The Lancet HIV, 2023 - thelancet.com
The effectiveness of HIV pre-exposure prophylaxis (PrEP) hinges on adherence, which has
been restricted by multifaceted barriers. Uptake of PrEP has been impeded by poor access …

Point-of-care and near real-time testing for antiretroviral adherence monitoring to HIV treatment and prevention

PK Drain, AR Bardon, JM Simoni, TR Cressey… - Current HIV/AIDS …, 2020 - Springer
Abstract Purpose of Review In this report, we review the need for point-of-care (POC) or near
real-time testing for antiretrovirals, progress in the field, evidence for guiding implementation …

Point-of-Care tenofovir urine testing for the prediction of treatment failure and drug resistance during initial treatment for human immunodeficiency virus type 1 (HIV-1) …

LE Hermans, CN Umunnakwe… - Clinical Infectious …, 2023 - academic.oup.com
Background Viral rebound during antiretroviral treatment (ART) is most often driven by
suboptimal adherence in the absence of drug resistance. We assessed the diagnostic …

Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following tenofovir alafenamide: the TAF-DBS study

J Yager, J Castillo-Mancilla, ME Ibrahim… - JAIDS Journal of …, 2020 - journals.lww.com
Background: Tenofovir alafenamide (TAF), in combination with FTC, was recently approved
for PrEP in the United States. The objective of this study was to assess the relationship …

Point-of-care urine tenofovir testing to predict HIV drug resistance among individuals with virologic failure

SM McCluskey, K Govender, J Adamson, M Gandhi… - AIDS, 2023 - journals.lww.com
Objective: We sought to evaluate the utility of a point-of-care (POC) urine tenofovir (TFV)
assay, developed to objectively assess adherence, to predict HIV drug resistance (HIVDR) …

Real-time monitoring and point-of-care testing: a review of the current landscape of PrEP adherence monitoring

A Hannaford, Y Arens, H Koenig - Patient preference and …, 2021 - Taylor & Francis
Background Despite pre-exposure prophylaxis (PrEP) being highly effective at preventing
HIV, HIV infections among individuals prescribed PrEP continue to occur. The vast majority …

Perspectives of people living with HIV and health workers about a point-of-care adherence assay: a qualitative study on acceptability

A Mcinziba, D Wademan, L Viljoen, H Myburgh… - AIDS care, 2023 - Taylor & Francis
Current antiretroviral therapy (ART) adherence monitoring is premised on patients' self-
reported adherence behaviour (prone to recall error) and verified by blood viral load …

Pre-exposure prophylaxis recent adherence with real-time adherence feedback and partner human immunodeficiency virus self-testing: a pilot trial among postpartum …

DL Joseph Davey, K Dovel, R Mvududu… - Open Forum …, 2022 - academic.oup.com
Abstract Background Pre-exposure prophylaxis (PrEP) is safe and effective in postpartum
women. Human immunodeficiency virus self-testing (HIVST) for male partners combined …